Covalon Technologies Ltd. (CVE:COV – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as C$3.31 and last traded at C$3.20, with a volume of 47076 shares trading hands. The stock had previously closed at C$3.17.
Covalon Technologies Trading Up 2.5 %
The company has a debt-to-equity ratio of 4.98, a quick ratio of 6.45 and a current ratio of 5.24. The firm has a market capitalization of C$80.18 million, a P/E ratio of -81.25 and a beta of 0.64. The firm has a 50 day simple moving average of C$2.57 and a two-hundred day simple moving average of C$1.85.
Covalon Technologies (CVE:COV – Get Free Report) last released its quarterly earnings results on Wednesday, August 21st. The company reported C$0.06 earnings per share for the quarter. Covalon Technologies had a negative net margin of 2.82% and a negative return on equity of 3.85%. The company had revenue of C$9.22 million for the quarter. Equities research analysts forecast that Covalon Technologies Ltd. will post 0.3 earnings per share for the current year.
Covalon Technologies Company Profile
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Featured Articles
- Five stocks we like better than Covalon Technologies
- Options Trading – Understanding Strike Price
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- 10 Best Airline Stocks to Buy
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- P/E Ratio Calculation: How to Assess Stocks
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.